Rajiv Patni - Jun 12, 2023 Form 3 Insider Report for REATA PHARMACEUTICALS INC (RETA)

Role: EVP, Chief R&D Officer
Signature: /s/ Tracy Herson, attorney-in-fact
Stock symbol: RETA
Transactions as of: Jun 12, 2023
Transactions value $: $0
Form type: 3
Date filed: 6/14/2023, 04:20 PM
Next filing: Sep 26, 2023
SEC: View on sec.gov

No securities are beneficially owned.

Remarks:

No securities are beneficially owned. Exhibit List: Power of Attorney